4880

Serial Number 97613272
Registration 7986110
700

Registration Progress

Application Filed
Sep 29, 2022
Under Examination
Jan 9, 2024
Approved for Publication
Nov 14, 2023
Published for Opposition
Nov 14, 2023
Registered
Oct 14, 2025

Trademark Image

4880

Basic Information

Serial Number
97613272
Registration Number
7986110
Filing Date
September 29, 2022
Registration Date
October 14, 2025
Published for Opposition
November 14, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 14, 2025
Registration
Registered
Classes
005

Rights Holder

Mallinckrodt Pharmaceuticals Ireland Limited

99
Address
College Business & Technology Park
Cruiserath Road, Blanchardstown
Dublin 15 D15TX2V
IE

Ownership History

Mallinckrodt Pharmaceuticals Ireland Limited

Original Applicant
99
Dublin 15 IE

Mallinckrodt Pharmaceuticals Ireland Limited

Owner at Publication
99
Dublin 15 IE

Mallinckrodt Pharmaceuticals Ireland Limited

Original Registrant
99
Dublin 15 IE

Legal Representation

Attorney
Hillary Maynard

USPTO Deadlines

Next Deadline
2082 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20251014)
Due Date
October 14, 2031
Grace Period Ends
April 14, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

30 events
Date Code Type Description Documents
Oct 14, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Oct 14, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 23, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Sep 23, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Sep 20, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Apr 28, 2025 IUAF S USE AMENDMENT FILED Loading...
Sep 20, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 28, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 6, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 6, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 6, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 8, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 8, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 8, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 8, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 9, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 14, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 14, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 25, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 12, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 11, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 11, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 11, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 13, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 13, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 13, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 13, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 3, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 3, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, nitric oxide for inhalation for treating pulmonary hypertension and conditions associated with pulmonary hypertension
First Use Anywhere: Mar 7, 2024
First Use in Commerce: Mar 7, 2024

Classification

International Classes
005